Snippet Search

Searching 12,245,596 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 1096 matching articles

Results per page:

... TMA bevacizumab, gemcitabine, cisplatin,  mitomycin 
Guidelines for treatment of renal injury during cancer chemotherapy 2016
Guidelines for treatment of renal injury during cancer chemotherapy 2016
Horie, Shigeo; Oya, Mototsugu; Nangaku, Masaomi; Yasuda, Yoshinari; Komatsu, Yasuhiro; Yanagita, Motoko; Kitagawa, Yuko; Kuwano, Hiroyuki; Nishiyama, Hiroyuki; Ishioka, Chikashi; Takaishi, Hiromasa; Shimodaira, Hideki; Mogi, Akira; Ando, Yuichi; Matsumoto, Koji; Kadowaki, Daisuke; Muto, Satoru
C, interferon Glomerular abnormalities ...
... chemotherapy with 5-FU + doxorubicin +  mitomycin 
Guidelines for chemotherapy of biliary tract and ampullary carcinomas
Guidelines for chemotherapy of biliary tract and ampullary carcinomas
Furuse, Junji; Takada, Tadahiro; Miyazaki, Masaru; Miyakawa, Shuichi; Tsukada, Kazuhiro; Nagino, Masato; Kondo, Satoshi; Saito, Hiroya; Tsuyuguchi, Toshio; Hirata, Koichi; Kimura, Fumio; Yoshitomi, Hideyuki; Nozawa, Satoshi; Yoshida, Masahiro; Wada, Keita; Amano, Hodaka; Miura, Fumihiko
C (FAM) and palliative treatment, such as ...
... (%) Deatha P-value 1 Niimoto et al. [13] A:  Mitomycin 
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer
Oba, Koji; Teramukai, Satoshi; Kobayashi, Michiya; Matsui, Takanori; Kodera, Yasuhiro; Sakamoto, Junichi
C (MMC) 20 mg i.v. day 1, futraful (FT) ...
... of 17 patients who received cisplatin,  mitomycin 
Randomized Comparison of Intra-Arterial Chemotherapy Versus Intra-Arterial Chemotherapy and Gelfoam Embolization for Treatment of Advanced Cervical Carcinoma
Randomized Comparison of Intra-Arterial Chemotherapy Versus Intra-Arterial Chemotherapy and Gelfoam Embolization for Treatment of Advanced Cervical Carcinoma
Ikeda, O.; Mizukami, N.; Murata, Y.; Arakawa, A.; Katabuchi, H.; Okamoto, H.; Yasunaga, T.; Tsunawaki, A.; Yamashita, Y.
, doxorubicin hydrochloride, and ...
... at clonal density on a feeder layer of  mitomycin 
Efficient expansion of human keratinocyte stem/progenitor cells carrying a transgene with lentiviral vector
Efficient expansion of human keratinocyte stem/progenitor cells carrying a transgene with lentiviral vector
Nanba, Daisuke; Matsushita, Natsuki; Toki, Fujio; Higashiyama, Shigeki
C-treated 3 T3-J2 cells at 37°C as ...
... and uracil (UFT) on tamoxifen (TAM) plus  mitomycin 
Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer
Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer
Ogita, Masami; Uchino, Junichi; Asaishi, Kazuaki; Kubo, Yoshihiko; Tanabe, Tatsuzo; Hata, Atsunobu; Hirata, Koichi; Mito, Michio
(MM) in patients with ...
... Moreover, both mutants were sensitive to  mitomycin 
Identification of temperature-sensitive dnaD mutants of Staphylococcus aureus that are defective in chromosomal DNA replication
Identification of temperature-sensitive dnaD mutants of Staphylococcus aureus that are defective in chromosomal DNA replication
Li, Y.; Kurokawa, K.; Matsuo, M.; Fukuhara, N.; Murakami, K.; Sekimizu, K.
C, a drug that induces DNA damage, ...
... Monotherapy with paclitaxel, cisplatin, or  mitomycin 
Evaluation of paclitaxel against human adenocarcinoma of the uterine cervix in nude mice
Evaluation of paclitaxel against human adenocarcinoma of the uterine cervix in nude mice
Fushiki, Hiroshi; Fujimura, Masaki; Izumi, Rikuichi
C, and combination therapy with ...
... mitotically inactivated by treatment with  mitomycin 
Derivation of Human Induced Pluripotent Stem Cells on Autologous Feeders
Derivation of Human Induced Pluripotent Stem Cells on Autologous Feeders
Takahashi, Kazutoshi
C or γ-ray irradiation. ...
... (Sigma, D2650) 10 ml FBS (Hyclone) 2 ml 7.  Mitomycin 
Definitive Endoderm Differentiation of Human Embryonic Stem Cells Combined with Selective Elimination of Undifferentiated Cells by Methionine Deprivation
Definitive Endoderm Differentiation of Human Embryonic Stem Cells Combined with Selective Elimination of Undifferentiated Cells by Methionine Deprivation
Tsuyama, Tomonori; Shiraki, Nobuaki; Kume, Shoen
C solution. ...
... Kyowa Hakko, Tokyo, Japan) and 4 mg of  mitomycin 
Combined Use of an Occlusion Balloon Catheter and a Microcatheter for Embolization of the Unselectable Right Inferior Phrenic Artery Supplying Hepatocellular Carcinoma
Combined Use of an Occlusion Balloon Catheter and a Microcatheter for Embolization of the Unselectable Right Inferior Phrenic Artery Supplying Hepatocellular Carcinoma
Miyayama, Shiro; Matsui, Osamu; Taki, Keiichi; Minami, Tetsuya; Ito, Chiharu; Shinmura, Rieko; Takamatsu, Shigeyuki; Kobayashi, Miki; Notsumata, Kazuo
C ( ...
... (Sigma, D2650) 10 mL FBS (Hyclone) 2 mL 7.  Mitomycin 
Hepatic Differentiation from Human Ips Cells Using M15 Cells
Hepatic Differentiation from Human Ips Cells Using M15 Cells
Umeda, Kahoko; Shiraki, Nobuaki; Kume, Shoen
C solution. ...
... Invitrogen) Gelatin (G1890, Sigma)  Mitomycin 
Generation of Induced Pluripotent Stem Cells from Mesenchymal Stromal Cells Derived from Human Third Molars (Method)
Generation of Induced Pluripotent Stem Cells from Mesenchymal Stromal Cells Derived from Human Third Molars (Method)
Oda, Yasuaki; Ohnishi, Hiroe; Yuba, Shunsuke; Ohgushi, Hajime
C (134-07911, Wako, Japan) FuGENE® HD ...
... Parentheses, percentage Epi epirubicin, MMC  mitomycin 
Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?
Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?
Yamakado, Koichiro; Miyayama, Shiro; Hirota, Shozo; Mizunuma, Kimiyoshi; Nakamura, Kenji; Inaba, Yoshitaka; Maeda, Akihiro; Matsuo, Kunihiro; Nishida, Norifumi; Aramaki, Takeshi; Anai, Hiroshi; Koura, Shinichi; Oikawa, Shigeo; Watanabe, Ken; Yasumoto, Taku; Furuichi, Kinya; Yamaguchi, Masato
C The mean maximum tumor diameter was ...
... with intraperitoneal cisplatin and early  mitomycin 
Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2
Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2
Miyashiro, Isao; Furukawa, Hiroshi; Sasako, Mitsuru; Yamamoto, Seiichiro; Nashimoto, Atsushi; Nakajima, Toshifusa; Kinoshita, Taira; Kobayashi, Osamu; Arai, Kuniyoshi; The Gastric Cancer Surgical Study Group in the Japan Clinical Oncology Group
-C plus long-term doxifluridine plus ...
... Background, Aims and Methods  Mitomycin 
Detection of mitomycin C-induced testicular toxicity by micronucleus assay in mice
Detection of mitomycin C-induced testicular toxicity by micronucleus assay in mice
Nakagawa, Soichi; Mori, Chisato
C is a promising cancer agent that has been ...
... of the commonly prescribed 28-day MVP (  mitomycin 
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer
Takada, Minoru; Fukuoka, Masahiro; Ariyoshi, Yutaka; Furuse, Kiyoyuki; Niitani, Hisanobu; Ota, Kazuo; Motomiya, Masakichi; Hasegawa, Kouichi; Tominaga, Keigo; Kuriyama, Takayuki; Yoshida, Kiyokazu; Kimura, Hitoshi; Kurita, Yuzo; Nakajima, Shigenori; Nakai, Jun; Ohta, Mituo; Yamamoto, Hidehiko
C, vindesine, and cisplatin) regimen in ...
... cultured for 24 h and treated with  mitomycin 
Common Variable Immunodeficiency Caused by FANC Mutations
Common Variable Immunodeficiency Caused by FANC Mutations
Sekinaka, Yujin; Mitsuiki, Noriko; Imai, Kohsuke; Yabe, Miharu; Yabe, Hiromasa; Mitsui-Sekinaka, Kanako; Honma, Kenichi; Takagi, Masatoshi; Arai, Ayako; Yoshida, Kenichi; Okuno, Yusuke; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Muramatsu, Hideki; Kojima, Seiji; Hira, Asuka; Takata, Minoru; Ohara, Osamu; Ogawa, Seishi; Morio, Tomohiro; Nonoyama, Shigeaki
C 0.1 μg/mL [22]. ...
... complication after filtration surgery with  mitomycin 
Suppression of avascular bleb formation by a thin biodegradable film in a rabbit filtration surgery with mitomycin C
Suppression of avascular bleb formation by a thin biodegradable film in a rabbit filtration surgery with mitomycin C
Okuda, Tetsuhiko; Higashide, Tomomi; Fukuhira, Yukako; Kaneko, Hiroaki; Shimomura, Masatsugu; Sugiyama, Kazuhisa
C (MMC). ...
... autoclaving. Store at room temperature. 10.  Mitomycin 
Embryonic Stem Cells as a Model for Studying Osteoclast Lineage Development
Embryonic Stem Cells as a Model for Studying Osteoclast Lineage Development
Yamane, Toshiyuki; Kunisada, Takahiro; Hayashi, Shin-Ichi
C (Sigma, cat. no. M0503): For 100X ...
... (Sigma, D2650) 10 mL FBS (Hyclone) 2 mL 7.  Mitomycin 
Definitive Endoderm Differentiation of Human Embryonic Stem Cells Combined with Selective Elimination of Undifferentiated Cells by Methionine Deprivation
Definitive Endoderm Differentiation of Human Embryonic Stem Cells Combined with Selective Elimination of Undifferentiated Cells by Methionine Deprivation
Tsuyama, Tomonori; Shiraki, Nobuaki; Kume, Shoen
C solution. ...
... autoclaving. Store at room temperature. 9.  Mitomycin 
Embryonic Stem Cells as a Model for Studying Melanocyte Development
Embryonic Stem Cells as a Model for Studying Melanocyte Development
Yamane, Toshiyuki; Hayashi, Shin-Ichi; Kunisada, Takahiro
C (Sigma, cat. no. M0503). For a 100X ...
... chemosensitivity to doxorubicin (DOX),  mitomycin 
Targeted therapy against Bcl-2-related proteins in breast cancer cells
Targeted therapy against Bcl-2-related proteins in breast cancer cells
Emi, Manabu; Kim, Ryungsa; Tanabe, Kazuaki; Uchida, Yoko; Toge, Tetsuya
C (MMC), paclitaxel (TXL), and docetaxel ...
... (100X; Sigma, cat. no. P0781). 20.  Mitomycin 
Neural Stem Sphere Method
Neural Stem Sphere Method
Nakayama, Takashi; Inoue, Nobuo
C (10 mg; Wako, cat. no. 134-07911) (see ...
... without induction chemotherapy comprising  mitomycin 
Current status of induction treatment for N2-Stage III non-small cell lung cancer
Current status of induction treatment for N2-Stage III non-small cell lung cancer
Yamaguchi, Masafumi; Sugio, Kenji
, ifosfamide and cisplatin. ...